<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">Cerebral embolism</z:e> from cardiac source is an important cause of <z:hpo ids='HP_0001297'>stroke</z:hpo>, specially in patients younger than 45 years old </plain></SENT>
<SENT sid="1" pm="."><plain>OBJECTIVE: To describe the transesophageal echocardiography (TEE) findings in young and non-young <z:hpo ids='HP_0001297'>stroke</z:hpo> patients without any prior evidence of cardiac source for <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHOD: Transversal study: 523 patients (267 men and 256 women) with <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo>, without any evidence of <z:hpo ids='HP_0001627'>cardiac abnormality</z:hpo>, underwent to TEE </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Ten percent were aged 45 years; or less </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0002625'>Left ventricle hypertrophy</z:mp>, left atrial enlargement, spontaneous contrast in aorta, interatrial septum <z:hpo ids='HP_0002617'>aneurysm</z:hpo>, mitral and <z:hpo ids='HP_0004380'>aortic valve calcification</z:hpo>, <z:hpo ids='HP_0001659'>aortic valve regurgitation</z:hpo>, and atherosclerotic plaques in aorta were significantly more frequent in patients aged more than 45 years; 2.8% of non-young patients had <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> in left heart </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSION: TEE is widely used to diagnose cardiac source of <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> in young patients, but it seems to be as useful for older ones, in whom <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> risk is underestimated; atherogenic and cardioembolic causes may actually coexist, and both should be treated </plain></SENT>
</text></document>